Altera Digital Health, a global healthcare IT innovator, today announced it has expanded its partnership with Pipeline Health, a community-based hospital system headquartered in Los Angeles. The seven-year contract will extend Pipeline Health’s use of the Paragon electronic health record (EHR) at four…
Spesana has announced the formation of the Spesana Advisory Board with appointments of experienced industry leaders across clinical sites, life science companies and diagnostic labs. The Advisory Board will collaborate on strategy for multiple healthcare stakeholders’ use of the Spesana…
a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure…
The Camille and Henry Dreyfus Foundation has announced that Xiaowei Zhuang, Howard Hughes Medical Institute Investigator and David B. Arnold Jr. Professor of Science, Harvard University, is the recipient of the 2023 Dreyfus Prize in the Chemical Sciences. The international biennial…
The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include…
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA) focused on delivering innovative therapies in critical care and infectious disease, today announced that The Lancet Infectious Diseases published detailed results from the pivotal Phase 3 ATTACK trial of sulbactam-durlobactam, the first…
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the promotion of Michael Sherman Blue, M.D., FACEP to the position of Chief Medical Officer (CMO),…
Scientist.com, der führende Marktplatz für präklinische Forschung für den biopharmazeutischen Sektor, gab heute die kürzliche Übernahme von Labs Explorer bekannt, einem bekannten französischen Netzwerk, das europäische Forschungslabore, wissenschaftliche Fachleute und innovative Start-ups miteinander verbindet. Dieser strategische Schritt verschafft den Nutzern…
FOXO Technologies Inc. (NYSEAM: FOXO) (“FOXO” or the “Company”), a leader in commercializing epigenetic biomarkers of health and aging, today reported financial results for the first quarter ended March 31, 2023. “The first quarter was a strong start to the…
a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the first quarter ended March 31, 2023 and will host a conference call today at 4:30 p.m. Eastern Time to discuss…
a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the first quarter 2023 and provided corporate and clinical…
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and oncologic disorders, today reported financial results for the first quarter ended March 31, 2023 and provided a business update. “This quarter,…